Similar articles

• Reconstitution of the purified receptor for calcium channel blockers.

  Sieber M, Nastainczyk W, Röhrkasten A, Hofmann F. Sieber M, et al. Biomed Biochim Acta. 1987;46(8-9):S357-62. Biomed Biochim Acta. 1987. PMID: 2829861
• Characterization of the drug receptors of the purified skeletal muscle calcium channel.

  Striessnig J, Glossmann H. Striessnig J, et al. Prog Clin Biol Res. 1988;252:35-40. Prog Clin Biol Res. 1988. PMID: 2450374 No abstract available.
• Purified dihydropyridine-binding site from skeletal muscle t-tubules is a functional calcium channel.

  Flockerzi V, Oeken HJ, Hofmann F, Pelzer D, Cavalié A, Trautwein W. Flockerzi V, et al. Nature. 1986 Sep 4-10;323(6083):66-8. doi: 10.1038/323066a0. Nature. 1986. PMID: 2427959
• Calcium-antagonist drugs. Receptor interactions that clarify therapeutic effects.

  Snyder SH, Reynolds IJ. Snyder SH, et al. N Engl J Med. 1985 Oct 17;313(16):995-1002. doi: 10.1056/NEJM198510173131606. N Engl J Med. 1985. PMID: 2413355 Review. No abstract available.
• The 1,4-dihydropyridine receptor: a regulatory component of the Ca2+ channel.

  Triggle DJ, Janis RA. Triggle DJ, et al. J Cardiovasc Pharmacol. 1984;6 Suppl 7:S949-55. J Cardiovasc Pharmacol. 1984. PMID: 6085383 Review.